Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Preferred Dividend Payments (2018 - 2021)

Surgery Partners' Preferred Dividend Payments history spans 4 years, with the latest figure at $10.3 million for Q1 2021.

  • For Q1 2021, Preferred Dividend Payments rose 8.42% year-over-year to $10.3 million; the TTM value through Dec 2021 reached $10.3 million, down 73.92%, while the annual FY2021 figure was $10.3 million, 73.92% down from the prior year.
  • Preferred Dividend Payments for Q1 2021 was $10.3 million at Surgery Partners, roughly flat from $10.3 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $32.4 million in Q4 2018 and bottomed at $7.8 million in Q1 2018.
  • The 4-year median for Preferred Dividend Payments is $9.3 million (2019), against an average of $10.9 million.
  • The largest annual shift saw Preferred Dividend Payments crashed 71.3% in 2019 before it grew 11.76% in 2020.
  • A 4-year view of Preferred Dividend Payments shows it stood at $32.4 million in 2018, then plummeted by 71.3% to $9.3 million in 2019, then grew by 10.75% to $10.3 million in 2020, then changed by 0.0% to $10.3 million in 2021.
  • Per Business Quant, the three most recent readings for SGRY's Preferred Dividend Payments are $10.3 million (Q1 2021), $10.3 million (Q4 2020), and $10.0 million (Q3 2020).